| Product Code: ETC12942589 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina mRNA Therapeutics Contract Development Manufacturing Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Argentina mRNA Therapeutics Contract Development Manufacturing Market - Industry Life Cycle |
3.4 Argentina mRNA Therapeutics Contract Development Manufacturing Market - Porter's Five Forces |
3.5 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Argentina mRNA Therapeutics Contract Development Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in mRNA therapeutics research and development in Argentina |
4.2.2 Growing demand for contract development and manufacturing services in the mRNA therapeutics sector |
4.2.3 Technological advancements in mRNA therapeutics manufacturing processes |
4.3 Market Restraints |
4.3.1 Regulatory challenges and uncertainties in the mRNA therapeutics market in Argentina |
4.3.2 Limited expertise and infrastructure for mRNA therapeutics manufacturing in the region |
5 Argentina mRNA Therapeutics Contract Development Manufacturing Market Trends |
6 Argentina mRNA Therapeutics Contract Development Manufacturing Market, By Types |
6.1 Argentina mRNA Therapeutics Contract Development Manufacturing Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Service Type, 2021 - 2031F |
6.1.3 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Process Development, 2021 - 2031F |
6.1.4 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Analytical Testing, 2021 - 2031F |
6.1.5 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Manufacturing, 2021 - 2031F |
6.1.6 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Formulation Development, 2021 - 2031F |
6.1.7 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Regulatory Support, 2021 - 2031F |
6.2 Argentina mRNA Therapeutics Contract Development Manufacturing Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By mRNA Vaccines, 2021 - 2031F |
6.2.3 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By mRNA Therapeutics, 2021 - 2031F |
6.2.4 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By mRNA Drug Delivery, 2021 - 2031F |
6.2.5 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.2.6 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Protein Replacement Therapy, 2021 - 2031F |
6.3 Argentina mRNA Therapeutics Contract Development Manufacturing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3.3 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Cancer Treatment, 2021 - 2031F |
6.3.4 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Rare Diseases, 2021 - 2031F |
6.3.5 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Genetic Disorders, 2021 - 2031F |
6.3.6 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Autoimmune Diseases, 2021 - 2031F |
6.4 Argentina mRNA Therapeutics Contract Development Manufacturing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4.3 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.4.4 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Contract Manufacturing Organizations, 2021 - 2031F |
6.4.5 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Clinical Research Organizations, 2021 - 2031F |
6.5 Argentina mRNA Therapeutics Contract Development Manufacturing Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Lipid Nanoparticles, 2021 - 2031F |
6.5.3 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By In Vitro Transcription, 2021 - 2031F |
6.5.4 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Encapsulation Methods, 2021 - 2031F |
6.5.5 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By CRISPR Technology, 2021 - 2031F |
6.5.6 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By AI-Based Quality Control, 2021 - 2031F |
7 Argentina mRNA Therapeutics Contract Development Manufacturing Market Import-Export Trade Statistics |
7.1 Argentina mRNA Therapeutics Contract Development Manufacturing Market Export to Major Countries |
7.2 Argentina mRNA Therapeutics Contract Development Manufacturing Market Imports from Major Countries |
8 Argentina mRNA Therapeutics Contract Development Manufacturing Market Key Performance Indicators |
8.1 Number of new mRNA therapeutics development projects initiated in Argentina |
8.2 Percentage increase in the outsourcing of mRNA therapeutics manufacturing services |
8.3 Adoption rate of advanced manufacturing technologies in mRNA therapeutics production in Argentina |
8.4 Number of collaborations between local and international companies in the mRNA therapeutics sector |
8.5 Percentage growth in investments in mRNA therapeutics contract development and manufacturing in Argentina |
9 Argentina mRNA Therapeutics Contract Development Manufacturing Market - Opportunity Assessment |
9.1 Argentina mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 Argentina mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Argentina mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Argentina mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Argentina mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Argentina mRNA Therapeutics Contract Development Manufacturing Market - Competitive Landscape |
10.1 Argentina mRNA Therapeutics Contract Development Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Argentina mRNA Therapeutics Contract Development Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here